Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Inaba

Showing results (521-530 of 534) with videos related to

Pageof 54
Sort By:
Internal Medicine (Tokyo, Japan)|October 3, 2001
Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHSC Shimazaki, T Inaba, A Okano, et al.
Bone Marrow Transplantation|April 1, 1997
Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantationC Shimazaki, T Inaba, H Uchiyama, et al.
The Journal of Biological Chemistry|November 6, 2009
The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liverJocelyn Trottier, Diala El Husseini, Martin Perreault, et al.
Leukemia|February 18, 2017
A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancersN Sugino, M Kawahara, G Tatsumi, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2016
Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcersT Kagawa, M Iwamuro, S Ishikawa, et al.
British Journal of Haematology|July 11, 2000
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphomaT Inaba, C Shimazaki, T Sumikuma, et al.
Journal of Viral Hepatitis|June 20, 2014
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1K Kosaka, M Imamura, C N Hayes, et al.
Leukemia|February 12, 2010
Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factorK Akahane, T Inukai, T Inaba, et al.
Leukemia|June 30, 2012
Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsX Zhang, T Inukai, K Hirose, et al.
Leukemia|October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSD Inoue, J Kitaura, H Matsui, et al.
Pageof 54

Showing results (521-530 of 534) with videos related to

Sort By:
Pageof 54
Internal Medicine (Tokyo, Japan)|October 3, 2001
Clinical characteristics of B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS): comparison of CD5+ with CD5- B-LAHSC Shimazaki, T Inaba, A Okano, et al.
Bone Marrow Transplantation|April 1, 1997
Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantationC Shimazaki, T Inaba, H Uchiyama, et al.
The Journal of Biological Chemistry|November 6, 2009
The human UGT1A3 enzyme conjugates norursodeoxycholic acid into a C23-ester glucuronide in the liverJocelyn Trottier, Diala El Husseini, Martin Perreault, et al.
Leukemia|February 18, 2017
A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancersN Sugino, M Kawahara, G Tatsumi, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2016
Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcersT Kagawa, M Iwamuro, S Ishikawa, et al.
British Journal of Haematology|July 11, 2000
Expression of T-cell-associated antigens in B-cell non-Hodgkin's lymphomaT Inaba, C Shimazaki, T Sumikuma, et al.
Journal of Viral Hepatitis|June 20, 2014
Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1K Kosaka, M Imamura, C N Hayes, et al.
Leukemia|February 12, 2010
Specific induction of CD33 expression by E2A-HLF: the first evidence for aberrant myeloid antigen expression in ALL by a fusion transcription factorK Akahane, T Inukai, T Inaba, et al.
Leukemia|June 30, 2012
Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptorsX Zhang, T Inukai, K Hirose, et al.
Leukemia|October 14, 2014
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDSD Inoue, J Kitaura, H Matsui, et al.
Pageof 54